Erin Henitz

Erin Henitz has a strong background in the pharmaceutical industry, with significant experience in various roles related to precision medicine, biomarker operations, and trial management. Erin is currently the Senior Director and Global Head of Precision Medicine Operations & Diagnostics at Genmab since January 2022. Prior to that, they held positions such as Senior Director, Head of Biomarker Operations and Trial Management at Genmab, Director, Team Lead, Biomarker Operations and Trial Management at Genmab, and Director, Biomarker Operations at Genmab. Additionally, they worked at The Janssen Pharmaceutical Companies of Johnson & Johnson, where they held the position of Director, Oncology Translational Research Operations Lead and Associate Director, Oncology Translational Research. Erin also has experience as a Manager of Oncology Biomarker Operations at The Janssen Pharmaceutical Companies of Johnson & Johnson. Erin began their career at Bristol-Myers Squibb as a Sample Bank Coordinator.

Erin Henitz pursued their education at the University of Maryland Global Campus from 2011 to 2013, where they obtained a Master of Science degree in Biotechnology Management. Prior to that, they attended Stockton University, graduating between 1999 and 2003, earning a Bachelor of Science degree in Biology.